AWAKN LIFE SCIENCES CORP Share · CA05455W1086 · A3CTL4 (NEOE) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of AWAKN LIFE SCIENCES CORP
No Price
Company Profile for AWAKN LIFE SCIENCES CORP Share
Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company is headquartered in Toronto, Canada.
Company Data
Name AWAKN LIFE SCIENCES CORP
Company Awakn Life Sciences Corp.
Website
https://awaknlifesciences.com
Primary Exchange 
Frankfurt
Frankfurt
WKN A3CTL4
ISIN CA05455W1086
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Anthony Tennyson
Country Canada
Currency EUR
Employees 0,0 T
Address 301-217 Queen Street West, M5V 0R2 Toronto
IPO Date 2021-06-23
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | AWKNF |
| Frankfurt | 954.F |
More Shares
Investors who hold AWAKN LIFE SCIENCES CORP also have the following shares in their portfolio:
